Veracyte Leadership

Our executive team and board bring deep life sciences and diagnostics expertise to help advance cancer care for patients worldwide.

Executive Team Board of Directors

Executive Team

The Veracyte executive team leads strategy, science, and operations to develop high-performing molecular tests that provide biological insights, helping clinicians and patients make more personalized, informed decisions in thyroid, prostate, breast, bladder, and lung cancer care.

Marc Stapley

Chief Executive Officer

Rebecca Chambers

Chief Financial Officer

Phillip G. Febbo, M.D.

Chief Scientific Officer & Chief Medical Officer

Steven French

Chief Information Officer

Keith Gligorich, Ph.D.

SVP, Global Operations

Kevin Haas, Ph.D.

Chief Development & Technology Officer

John Leite, Ph.D.

Global Chief Commercial Officer

Annie McGuire

General Counsel & Head of Market Access

Karen Possemato

SVP, Corporate Marketing, Communications & Commercial Operations

Tracy Ward

Chief Human Resources Officer

Jonathan Wygant

Chief Accounting Officer

Board of Directors

The Veracyte Board of Directors is comprised of experienced leaders in life sciences, genomics, artificial intelligence, and diagnostics. They provide governance and strategic guidance to expand access and adoption of the Veracyte Diagnostics Platform across the United States and worldwide.